Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

March 01, 2005 (Vol. 25, No. 5)

Managing Cardiovascular Disease Risk Factors

Fighting Fat with New Medicine

  • With the increasing recognition that maintenance of overall metabolic health is critical to preventing heart disease, pharmaceutical and biotech companies are focusing on developing drugs that act to reduce overall heart disease risk or individual risk components. These include obesity, smoking, dyslipidemias, and diabetes, among others. While the ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.